About the HPTN

Mission Statement

The HPTN is dedicated to the discovery and development of new and innovative research strategies to reduce the acquisition and transmission of HIV.

The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network that brings together investigators, ethicists, community and other partners to develop and test the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. HPTN studies evaluate new HIV prevention interventions and strategies in populations and geographical regions that bear a disproportionate burden of infection.

The HPTN research agenda is focused primarily on the use of integrated strategies: use of antiretroviral drugs (antiretroviral therapy and pre-exposure prophylaxis); interventions for substance abuse, particularly injection drug use; behavioral risk reduction interventions and structural interventions. The HPTN is committed to the highest ethical standards for its clinical trials and recognizes the importance of community engagement in all phases of the research process.

The HPTN was established in 2000, building on the work of the HIV Network for Prevention Trials (HIVNET). HPTN’s Leadership and Operations Center (LOC), is based at FHI 360, Durham, North Carolina. Its Laboratory Center (LC) is at Johns Hopkins University, Baltimore, Maryland and its Statistical and Data Management Center (SDMC) is housed within the Statistical Center for HIV/AIDS Research and Prevention (SCHARP) at the Fred Hutchinson Cancer Research Center in Seattle, Washington. The HPTN Modelling Centre, part of the SDMC, is a collaboration between the Department of Infectious Diseases Epidemiology at Imperial College London and SCHARP.

HPTN receives its funding from three NIH institutes: the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health and the National Institute on Drug Abuse.

Webinars

The HPTN Leadership and Operations Center (LOC)

The HPTN Statistical and Data Management Center (SDMC)


Conversations with the HPTN

Jirawat Suksamosorn (aka “Mod”) is an HPTN 083 community liaison at the Silom Community Clinic CRS in Bangkok. Mod has the critical role of connecting study teams to community partners and key stakeholders to ensure essential input and support of research and increase mutual understanding for the successful conduct of research trials. He brings to his work an extraordinary commitment to enhancing community engagement.

Tereza Omoro, a community engagement expert, is a member of the HPTN Community Working Groups supporting studies such as HVTN 703/HPTN 081 (AMP) and HPTN 084. She has worked in HIV prevention research as a community educator with Kenya Medical Research Institute (KEMRI) Kisumu CRS. 

Dr. Steven Shoptaw is protocol co-chair for HPTN 094, a professor in the University of California at Los Angeles (UCLA) departments of Family Medicine and Psychiatry and Biobehavioral Sciences, and professor (Hon.) in psychiatry at the University of Cape Town.

AJ Winingham, a member of the HPTN 083 Community Working Group, is a community outreach coordinator in the Division of Infectious Diseases at the Washington University School of Medicine in St. Louis. AJ completed an Associates of Arts Degree at St.